Alicia Forcada-Nadal

7PUBLICATIONS
27CO-AUTHORS
Microbial taxonomyBiologically active moleculesGenomics and transcriptomicsGlycoconjugatesNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 28, 2026
In Host Mutational Adaptation of Mycobacterium Tuberculosis Complex Strains During Tuberculosis Infection.

|Dec 01, 2025
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial Virus.

Olaia Martí-Marí, Marta Moreno-Simoni, Ana Isabel Avilés-Alía

|Sep 15, 2025
Exploring SARS-CoV‑2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological Approach.

Javier García-Marín, Clara Francés-Gómez, Alicia Forcada-Nadal

|Mar 04, 2025
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity.

Julia Revuelta, Luciana Rusu, Clara Frances-Gomez

|Feb 25, 2025
Structures of the cyanobacterial nitrogen regulators NtcA and PipX complexed to DNA shed light on DNA binding by NtcA and implicate PipX in the recruitment of RNA polymerase.

Alicia Forcada-Nadal, Sirine Bibak, Paloma Salinas

|Jul 20, 2023
C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein.

Marta Gargantilla, Clara Francés, Anmol Adhav

Pageof 2

Frequent Collaborators

5 joint publications

José-Luis Llacer

3 joint publications

Alberto Marina

2 joint publications

Vicente Rubio

2 joint publications

Clara Frances-Gomez